Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 34,681 |
|
|||||
| News | - | ||||||
| Day High | 2.7682 | Low High |
|||||
| Day Low | 2.53 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| VYNE Therapeutics Inc | VYNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.12 | 4.80% | 2.62 | 17:30:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.54 | 2.53 | 2.7682 | 2.62 | 2.50 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 255 | 34,681 | $ 2.63 | $ 91,071 | - | 1.67 - 8.81 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:03 | seq | 298 | $ 2.64 | USD |
VYNE Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 37.22M | 14.10M | - | 424k | -28.45M | -2.02 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
VYNE Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VYNE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.47 | 2.7682 | 2.40 | 2.53 | 37,083 | 0.15 | 6.07% |
| 1 Month | 2.86 | 3.0199 | 2.24 | 2.61 | 61,141 | -0.24 | -8.39% |
| 3 Months | 2.15 | 3.17 | 1.90 | 2.54 | 101,847 | 0.47 | 21.86% |
| 6 Months | 2.98 | 4.4808 | 1.67 | 2.54 | 102,707 | -0.36 | -12.08% |
| 1 Year | 6.01 | 8.81 | 1.67 | 2.97 | 146,714 | -3.39 | -56.41% |
| 3 Years | 90.18 | 91.62 | 1.67 | 19.08 | 713,886 | -87.56 | -97.09% |
| 5 Years | 106.56 | 237.60 | 1.67 | 95.96 | 1,245,884 | -103.94 | -97.54% |
VYNE Therapeutics Description
| VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its most advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. |
